Image: iStock/Pilin_Petunyia

AstraZeneca sets out on a $1bn 'Bicycle' path

By Dan Stanton

AstraZeneca has partnered with Bicycle Therapeutics in a potential $1bn deal to develop a new class of small molecules which have antibody-like properties.

The new FormPrep platform automates biologic formulation preparation. (iStock:

Unchained Labs continues breaking into biologics market

By Melissa Fassbender

Unchained Labs has acquired Freeslate, a provider of high-throughput solutions for biologics formulation development and small molecule chemistry – marking the company’s 4th acquisition in 12 months.

Eli Lilly and Merck & Co. talk outsourcing and complex manufacturing

Exclusive Interview

Lilly focuses in-house as manufacturing becomes more complex

By Dan Stanton

Eli Lilly is maintaining greater in-house control as manufacturing processes become more complex, whilst MSD is leveraging external over-capacity to fulfil its needs, the firms told during a recent visit to Ireland.

Softly, softly...

Softly, softly...

German pharmaceutical company Boehringer Ingelheim has signed a
long-term agreement with software company MDL Information Systems
to use its software technology for managing and deploying chemical
information systems.


Follow us


Featured Suppliers